We developed a set of methoxypoly(ethyleneglycol)-co-poly(N3-ε-caprolactone) (mPEG-N3PCL)copolymers with different types of amine linkers and investigated thecontribution of the introduced amino linker to the gene delivery efficiency ofnanoparticles. The nanoparticles were crosslinked from the caprolactone regionswith a redox-responsive linker. Formulation variables including Redox-crosslinkingand N:P ratio were examined to obtain nanoparticles with optimal size andhighest siRNA entrapment efficacy (EE). The nanoparticles were characterized byDLS, and nanodrop UV-vis spectroscopy.Nanoparticle size, polydispersity index and siRNAentrapment efficacy were found to depend on the all the examined formulationvariables specially the N:P ratio. The...
Small interfering RNAs have been an emerging medical treatment for molecular based diseases as they ...
Clinical translation of polymer-based nanocarriers for systemic delivery of RNA has been limited due...
Objective(s): P-glycoprotein (P-gp) is an efflux protein, the overexpression of which has been assoc...
We developed a set of methoxypoly(ethyleneglycol)-co-poly(N3-ε-caprolactone) (mPEG-N3PCL)copolymers ...
AbstractShort interfering ribonucleic acids (siRNAs) offer a highly specific and selective form of t...
© 2020 Elsevier B.V. Triple negative or basal-like breast cancer (TNBC) is characterised by aggressi...
Glioblastoma multiforme (GBM) is one of the most malignant brain tumors affecting adults. It is char...
peer reviewedThe development of an efficient small interfering RNA (siRNA) delivery system has held ...
Drug delivery systems in the size range of ~ 10-250 nm are enabling tools for the site-specific targ...
Drug delivery systems in the size range of ~ 10-250 nm are enabling tools for site-specific targetin...
The therapeutic efficacy of anticancer nanocarriers ishighly dependent on their size, shape, targeti...
Bioresponsive nanoparticles (NPs) are of interest for anticancer nanomedicines, owing to the possibi...
Multidrug resistance (MDR) is a problem that is often associated with a poor clinical outcome in che...
RNA interference (RNAi) is a post-transcriptional gene silencing mechanism that occurs naturally wit...
In chapter two, the development of new a nanoparticulate carrier system for gene delivery was descri...
Small interfering RNAs have been an emerging medical treatment for molecular based diseases as they ...
Clinical translation of polymer-based nanocarriers for systemic delivery of RNA has been limited due...
Objective(s): P-glycoprotein (P-gp) is an efflux protein, the overexpression of which has been assoc...
We developed a set of methoxypoly(ethyleneglycol)-co-poly(N3-ε-caprolactone) (mPEG-N3PCL)copolymers ...
AbstractShort interfering ribonucleic acids (siRNAs) offer a highly specific and selective form of t...
© 2020 Elsevier B.V. Triple negative or basal-like breast cancer (TNBC) is characterised by aggressi...
Glioblastoma multiforme (GBM) is one of the most malignant brain tumors affecting adults. It is char...
peer reviewedThe development of an efficient small interfering RNA (siRNA) delivery system has held ...
Drug delivery systems in the size range of ~ 10-250 nm are enabling tools for the site-specific targ...
Drug delivery systems in the size range of ~ 10-250 nm are enabling tools for site-specific targetin...
The therapeutic efficacy of anticancer nanocarriers ishighly dependent on their size, shape, targeti...
Bioresponsive nanoparticles (NPs) are of interest for anticancer nanomedicines, owing to the possibi...
Multidrug resistance (MDR) is a problem that is often associated with a poor clinical outcome in che...
RNA interference (RNAi) is a post-transcriptional gene silencing mechanism that occurs naturally wit...
In chapter two, the development of new a nanoparticulate carrier system for gene delivery was descri...
Small interfering RNAs have been an emerging medical treatment for molecular based diseases as they ...
Clinical translation of polymer-based nanocarriers for systemic delivery of RNA has been limited due...
Objective(s): P-glycoprotein (P-gp) is an efflux protein, the overexpression of which has been assoc...